a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRSGX | 41.51 | 0.49 | +1.19% |
Franklin Small-Mid Cap Growth A | |||
MLVAX | 21.90 | 0.12 | +0.55% |
MFS Low Volatility Equity A | |||
RLBAX | 36.16 | 0.11 | +0.31% |
American Funds American Balanced R1 | |||
RGSVX | 13.18 | 0.03 | +0.23% |
ClearBridge Global Infrastructure Inc IS | |||
GCMTX | 39.26 | N/A | N/A |
Goldman Sachs Mid Cap Value Inv |
A.I.dvisor indicates that over the last year, APLS has been loosely correlated with PGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then PGEN could also see price increases.
Ticker / NAME | Correlation To APLS | 1D Price Change % | ||
---|---|---|---|---|
APLS | 100% | +10.88% | ||
PGEN - APLS | 38% Loosely correlated | -0.03% | ||
ZYME - APLS | 38% Loosely correlated | +4.46% | ||
BCRX - APLS | 36% Loosely correlated | +1.47% | ||
INZY - APLS | 35% Loosely correlated | +4.46% | ||
ACLX - APLS | 35% Loosely correlated | +3.69% | ||
More |